Triple Negative Breast Cancer (TNBC), Early Setting
3 clinical trials · Condition
◉ Watch Triple Negative Breast Cancer (TNBC), Early Setting
| Record | Firm | Date |
|---|---|---|
| Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy. (NCT07551765) | Barts & The London NHS Trust | 2026-11-13 |
| Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy (NCT07486687) | The Netherlands Cancer Institute | 2026-04-01 |
| LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer (NCT06831955) | Universitaire Ziekenhuizen KU Leuven | 2026-02-01 |
Track Triple Negative Breast Cancer (TNBC), Early Setting automatically
Every clearance here is in the API, with alerts when new ones post.